Floatz logo

mlc1501

Strokes Thrombotic

Moleac Pte Ltd.Phase 2/3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Strokes Thrombotic cohort.

Asset / SponsorPhaseRating
MELATONIN
Hospital San Carlos, Madrid
Phase 4BB
WARFARIN
Wuhan Asia Heart Hospital
D
DABIGATRAN ETEXILATE
Wuhan Asia Heart Hospital
D

Same molecule, other indications

mlc1501 is also rated in:

ischemic strokeDormant
BB
Indicative ·
67 / 100
View asset →
stroke disorderDormant
B
Indicative ·
61 / 100
View asset →
intracranial embolismDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →